ncRNA name
hsa-miR-7-5p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
PARP1
Cancer name
Small Cell Lung Cancer
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-7-5p impeded Dox-induced HR repair by inhibiting the expression of HR repair factors (Rad51 and BRCA1) that resulted in resensitizing SCLC cells to doxorubicin.
Tissue resource
human small cell lung cancer cell lines H69
human small cell lung cancer doxorubicin-resistant cell lines H69AR
Experiment
qRT-PCR,Western blot,Dual-Luciferase reporter assay
Institute
American Type Culture Collection
Country
USA
Continent
North American